A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke
Clinical trial NCT05515393 · UNKNOWN
Trial details
- NCT number
- NCT05515393
- Sponsor
- Shijiazhuang Yiling Pharmaceutical Co. Ltd
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-24
- Primary completion
- 2023-12-30
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.